الصفحة الرئيسية>>Artilide fumarate

Artilide fumarate (Synonyms: Artilide fumarate; U 88943E; U88943E; U-88943E)

رقم الكتالوجGB62288

Artilide, also known as U88943 or U88943E, is a drug used for the treatment of cardiac arrhythmias.

Products are for research use only. Not for human use. We do not sell to patients.

Artilide fumarate التركيب الكيميائي

Cas No.: 133267-20-6

الحجم السعر المخزون الكميّة
1mg
150٫00
متوفر
5mg
350٫00
متوفر
10mg
550٫00
متوفر
25mg
950٫00
متوفر
50mg
1650٫00
متوفر
100mg
2950٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents
Artilide, also known as U88943 or U88943E, is a drug used for the treatment of cardiac arrhythmias. Artilide is a class III antiarrhythmic which is structurally-related to ibutilide and d,l-sotalol. Artilide had demonstrated inducibe ventricular arrhythmias prior to treatment. This antiarrhythmic action was associated with significant increases in ventricular refractoriness and monophasic action potential duration. Lower doses of artilide tended to reduce the incidence of spontaneous ventricular arrhythmias but these effects were not significant. These results are consistent with the concept that spontaneous and pacing induced ventricular arrhythmias result from different mechanisms, and that class III anti-arrhythmic agents are more effective in suppressing induced ventricular tachycardia due to reentry than spontaneous arrhythmias which result from nonreentrant mechanisms.

مراجعات

Review for Artilide fumarate

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Artilide fumarate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.